• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数和低密度脂蛋白胆固醇变化模式对正常成年人和糖尿病患者心血管疾病的影响。

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics.

机构信息

Research Institute, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.

出版信息

BMJ Open Diabetes Res Care. 2020 Dec;8(2). doi: 10.1136/bmjdrc-2020-001340.

DOI:10.1136/bmjdrc-2020-001340
PMID:33355207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757466/
Abstract

INTRODUCTION

To examine how the risk of cardiovascular disease changes according to degree of change in body mass index (BMI) and low-density lipoprotein (LDL)-cholesterol in patients with diabetes using the health medical examination cohort database of the National Health Insurance Service in Korea. In comparison, the pattern in a non-diabetic control group was also examined.

RESEARCH DESIGN AND METHODS

The study samples were 13 800 patients with type 2 diabetes and 185 898 non-diabetic controls, and their baseline characteristics and repeatedly measured BMI and LDL-cholesterol until occurrence of cardiovascular disease were collected in longitudinal data. We used the variability model that is joint of mixed effects and regression model, then estimated parameters about variability by Bayesian methods.

RESULTS

The risk of cardiovascular disease was increased significantly with high average real variability (ARV) of BMI in the patients with diabetes, but the risk of cardiovascular disease was not increased according to degree of ARV in non-diabetic controls. The Bayesian variability model was used to analyze the effects of BMI and LDL-cholesterol change pattern on development of cardiovascular disease in diabetics, showing that variability did not have a statistically significant effect on cardiovascular disease. This shows the danger of the former simple method when interpreting only the mean of the absolute value of the variation.

CONCLUSIONS

The approach of simple SD in previous studies for estimation of individual variability does not consider the order of observation. However, the Bayesian method used in this study allows for flexible modeling by superimposing volatility assessments on multistage models.

摘要

简介

本研究旨在利用韩国国家健康保险服务的健康体检队列数据库,探讨糖尿病患者的体重指数(BMI)和低密度脂蛋白胆固醇(LDL-C)变化程度与心血管疾病风险之间的关系。同时,还对非糖尿病对照组的模式进行了研究。

研究设计与方法

研究样本包括 13800 例 2 型糖尿病患者和 185898 例非糖尿病对照者,收集了他们的基线特征以及在纵向数据中反复测量的 BMI 和 LDL-C,直至发生心血管疾病。我们使用了混合效应和回归模型的联合变异性模型,然后通过贝叶斯方法估计了变异性的参数。

结果

在糖尿病患者中,BMI 的平均真实变异性(ARV)较高时,心血管疾病的风险显著增加,但在非糖尿病对照组中,ARV 程度与心血管疾病风险之间没有显著相关性。贝叶斯变异性模型用于分析 BMI 和 LDL-C 变化模式对糖尿病患者心血管疾病发展的影响,结果显示变异性对心血管疾病没有统计学意义的影响。这表明了在解释变异的绝对值时,仅使用平均值的传统方法存在一定的危险。

结论

之前研究中用于估计个体变异性的简单标准差方法没有考虑观察的顺序。然而,本研究中使用的贝叶斯方法允许通过在多阶段模型上叠加波动率评估来进行灵活建模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec49/7757466/d1bf3ebb3108/bmjdrc-2020-001340f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec49/7757466/fd2f6adb2cc6/bmjdrc-2020-001340f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec49/7757466/d1bf3ebb3108/bmjdrc-2020-001340f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec49/7757466/fd2f6adb2cc6/bmjdrc-2020-001340f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec49/7757466/d1bf3ebb3108/bmjdrc-2020-001340f02.jpg

相似文献

1
Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics.体重指数和低密度脂蛋白胆固醇变化模式对正常成年人和糖尿病患者心血管疾病的影响。
BMJ Open Diabetes Res Care. 2020 Dec;8(2). doi: 10.1136/bmjdrc-2020-001340.
2
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus.韩国 2 型糖尿病患者的合并症和低密度脂蛋白胆固醇与心血管结局的关系。
Diabetes Metab J. 2023 Jan;47(1):45-58. doi: 10.4093/dmj.2021.0344. Epub 2023 Jan 26.
3
The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.社会经济地位对高危II型糖尿病非裔美国人心血管危险因素的影响。对X综合征的启示。
Diabetes Care. 1997 May;20(5):745-52. doi: 10.2337/diacare.20.5.745.
4
Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study.在患有心血管疾病或糖尿病的韩国成年人中,高敏 C 反应蛋白水平与心血管危险因素的相关性:CALLISTO 研究。
J Atheroscler Thromb. 2013;20(7):616-22. doi: 10.5551/jat.16089. Epub 2013 May 16.
5
Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.2型糖尿病患者血脂异常模式及非高密度脂蛋白胆固醇作为心血管疾病危险因素标志物的评估
Nepal Med Coll J. 2012 Dec;14(4):278-82.
6
Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.韩国心血管疾病和糖尿病高危患者的低密度脂蛋白胆固醇目标达标率:一项回顾性队列研究。
Lipids Health Dis. 2020 Jan 11;19(1):5. doi: 10.1186/s12944-019-1158-5.
7
Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.血压、血糖和胆固醇浓度及体重指数变异性与一般人群死亡率和心血管结局的关系。
Circulation. 2018 Dec 4;138(23):2627-2637. doi: 10.1161/CIRCULATIONAHA.118.034978.
8
Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.经皮冠状动脉介入治疗后随访 LDL、HDL 和非 HDL-胆固醇变异性对死亡率和心血管结局的影响。
Atherosclerosis. 2018 Dec;279:1-9. doi: 10.1016/j.atherosclerosis.2018.10.012. Epub 2018 Oct 17.
9
GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.2 型糖尿病患者的低密度脂蛋白胆固醇变异性增加心血管事件风险。
Endocr Pract. 2019 Sep;25(9):918-925. doi: 10.4158/EP-2019-0002. Epub 2019 May 9.
10
Evaluation of non-HDL-c and total cholesterol: HDL-c ratio as cumulative marker of cardiovascular risk in diabetes mellitus.非高密度脂蛋白胆固醇与总胆固醇:高密度脂蛋白胆固醇比值作为糖尿病心血管风险累积标志物的评估
Kathmandu Univ Med J (KUMJ). 2010 Oct-Dec;8(32):398-404. doi: 10.3126/kumj.v8i4.6239.

引用本文的文献

1
Association of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) with COPD prevalence and all-cause mortality: a population-based study based on NHANES 2007-2016.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)与慢性阻塞性肺疾病患病率及全因死亡率的关联:一项基于2007 - 2016年美国国家健康与营养检查调查(NHANES)的人群研究。
Front Med (Lausanne). 2025 Apr 3;12:1533744. doi: 10.3389/fmed.2025.1533744. eCollection 2025.
2
Sarcosine, Trigonelline and Phenylalanine as Urinary Metabolites Related to Visceral Fat in Overweight and Obesity.肌氨酸、胡芦巴碱和苯丙氨酸作为超重和肥胖人群中与内脏脂肪相关的尿液代谢产物
Metabolites. 2024 Sep 10;14(9):491. doi: 10.3390/metabo14090491.
3

本文引用的文献

1
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
2
Associations of changes in body mass index with all-cause and cardiovascular mortality in healthy middle-aged adults.健康中年成年人身体质量指数变化与全因死亡率和心血管死亡率的关联。
PLoS One. 2017 Dec 7;12(12):e0189180. doi: 10.1371/journal.pone.0189180. eCollection 2017.
3
Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohorts.
基于机器学习的糖尿病患者心血管疾病预测模型:两项独立韩国队列研究的验证。
Sci Rep. 2024 Jun 28;14(1):14966. doi: 10.1038/s41598-024-63798-y.
4
Associations of variability in body mass index with cardiovascular outcomes in the general population: A systematic review.普通人群中体重指数变异性与心血管结局的关联:一项系统评价。
JRSM Cardiovasc Dis. 2024 May 7;13:20480040241234149. doi: 10.1177/20480040241234149. eCollection 2024 Jan-Dec.
5
High Variability of Body Mass Index Is Independently Associated With Incident Heart Failure.体重指数的高度变异性与心力衰竭事件的发生独立相关。
J Am Heart Assoc. 2024 May 7;13(9):e031861. doi: 10.1161/JAHA.123.031861. Epub 2024 Apr 30.
6
Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?不良妊娠结局与动脉粥样硬化未来发展之间存在关联吗?
Biomedicines. 2023 Aug 31;11(9):2430. doi: 10.3390/biomedicines11092430.
7
Development of Data Mining Algorithms for Identifying the Best Anthropometric Predictors for Cardiovascular Disease: MASHAD Cohort Study.挖掘数据算法以识别心血管疾病最佳人体测量预测因子的发展:MASHAD 队列研究。
High Blood Press Cardiovasc Prev. 2023 May;30(3):243-253. doi: 10.1007/s40292-023-00577-2. Epub 2023 May 19.
8
Repercussions of absolute and time-rated BMI "yo-yo" fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort.绝对和时间评定 BMI“溜溜球”波动对血管代谢 CUN 队列心血管应激相关疾病的影响。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1087554. doi: 10.3389/fendo.2022.1087554. eCollection 2022.
9
Weight variability and cardiovascular outcomes: a systematic review and meta-analysis.体重变化与心血管结局:系统评价和荟萃分析。
Cardiovasc Diabetol. 2023 Jan 9;22(1):5. doi: 10.1186/s12933-022-01735-x.
10
Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.在糖尿病心血管风险控制行动(ACCORD)试验中,脂变异性与微血管并发症风险:事后分析。
J Diabetes. 2022 Jun;14(6):365-376. doi: 10.1111/1753-0407.13273. Epub 2022 Jun 6.
Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.
2002 - 2013年韩国成年2型糖尿病患者抗糖尿病药物使用趋势:基于全国人口的队列研究。
Medicine (Baltimore). 2016 Jul;95(27):e4018. doi: 10.1097/MD.0000000000004018.
4
Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service.一项使用国民健康保险服务建立的全国健康信息数据库的全国性基于人群研究的数据分析过程。
Diabetes Metab J. 2016 Feb;40(1):79-82. doi: 10.4093/dmj.2016.40.1.79.
5
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.2 型糖尿病强化生活方式干预的心血管效应。
N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24.
6
Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.高密度脂蛋白胆固醇变化与 2 型糖尿病患者冠心病或脑卒中住院风险的关系。
Am J Cardiol. 2011 Oct 15;108(8):1124-8. doi: 10.1016/j.amjcard.2011.05.047.
7
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.适度减轻体重对改善 2 型糖尿病超重和肥胖患者心血管危险因素的益处。
Diabetes Care. 2011 Jul;34(7):1481-6. doi: 10.2337/dc10-2415. Epub 2011 May 18.
8
The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes.“为何等待”项目:通过2型糖尿病的体重管理改善临床结局
Curr Diab Rep. 2008 Oct;8(5):413-20. doi: 10.1007/s11892-008-0071-5.
9
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.肥胖与心血管疾病:病理生理学、评估及体重减轻的影响:营养、身体活动与新陈代谢委员会肥胖问题委员会对1997年美国心脏协会关于肥胖与心脏病科学声明的更新
Circulation. 2006 Feb 14;113(6):898-918. doi: 10.1161/CIRCULATIONAHA.106.171016. Epub 2005 Dec 27.
10
Changes in BMI and weight before and after the development of type 2 diabetes.2型糖尿病发生前后体重指数(BMI)和体重的变化。
Diabetes Care. 2001 Nov;24(11):1917-22. doi: 10.2337/diacare.24.11.1917.